News

Please join Hogan Lovells and CAPCO for a webinar on Thursday, May 20 for a panel discussion on the LIBOR SOFR transition and how mortgage companies can manage the process.

Join Mitratech Interact EMEA 2021 Join a virtual gathering of the world’s foremost community of risk mitigation and operational excellence professionals, all dedicated to digital transformation of corporate legal operations and risk & compliance management.

Biden’s Labor Agenda Through Executive Action and Changes At the Department of Labor - Before the 2020 election, then US Presidential candidate Joe Biden vowed to be the “strongest labor president you have ever had.” And after a little more than 100 days, President Biden shows every sign of liv

Cybersecurity risk is evolving and expanding. Traditionally, cybersecurity risk has been equated with cyber attacks and associated legal consequences.

In today’s edition of Daily Compliance News: Getting back to the office. (FT) The ordeal when whistleblowers seek redress. (FT) How to cultivate a corp culture? (Hint-accountability) (FT) 1MDB goes after JPMorgan and Deutsche Bank. (FT)...

Kayvan Alikhani is the CEO and co-founder of Compliance.ai, a company dedicated to empowering professionals with the smartest regulatory and compliance change management platform. He has over thirty years of experience and expertise in software and cybersecurity.

Welcome back to the Law School Toolbox podcast! Today, we have ex-BigLaw recruiter Sadie Jones with us to talk about how virtual summer jobs went last year and what to think about if you're going to be working this summer.

On April 29, 2021, the FTC announced a $20 million settlement with Vivint Smart Home, Inc. (Vivint), a national seller of in-home security and monitoring systems, based on violations of the Fair Credit Reporting Act, the FTC Act, and the Red Flags Rule.

Restrictive covenants have a significant and substantial impact on the use and value of property; yet they are often ignored entirely or not considered until the end of the due diligence period before purchasing the property....

During the first quarter of 2021, multiple companies launched adalimumab biosimilars as a growing number of biosimilar players marketed their versions of the world’s most profitable drug, Humira®, which had sales of about $20 billion in 2020.

Pages